RPg Family Wealth Advisory’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$2.7M	Buy	21,109 +2,304	+12%	+$288K	0.56%	58
2025 Q4	$2.29M	Buy	18,805 +526	+3%	+$60.3K	0.5%	70
2025 Q3	$1.83M	Buy	18,279 +1,621	+10%	+$146K	0.4%	76
2025 Q2	$1.38M	Sell	16,658 -3,355	-17%	-$268K	0.37%	77
2025 Q1	$1.62M	Buy	20,013 +2,109	+12%	+$189K	0.46%	64
2024 Q4	$1.61M	Buy	17,904 +200	+1%	+$19.4K	0.57%	52
2024 Q3	$1.75M	Buy	17,704 +663	+4%	+$65.1K	0.56%	50
2024 Q2	$1.58M	Buy	17,041 +687	+4%	+$61.6K	0.52%	52
2024 Q1	$1.55M	Buy	16,354 +1,816	+12%	+$169K	0.49%	55
2023 Q4	$1.3M	Buy	14,538 +674	+5%	+$50.1K	0.48%	64
2023 Q3	$1.01M	Sell	13,864 -1,820	-12%	-$145K	0.42%	65
2023 Q2	$1.3M	Buy	15,684 +1,065	+7%	+$89.1K	0.52%	57
2023 Q1	$1.11M	Buy	14,619 +1,880	+15%	+$156K	0.61%	50
2022 Q4	$1.06M	Buy	12,739 +5,623	+79%	+$455K	0.72%	41
2022 Q3	$596K	Hold	7,116	–	–	0.31%	59
2022 Q2	$529K	Buy	7,116 +96	+1%	+$7.21K	0.32%	56
2022 Q1	$631K	Buy	7,020 +166	+2%	+$15.3K	0.27%	63
2021 Q4	$767K	Buy	6,854 +197	+3%	+$23.8K	0.3%	54
2021 Q3	$837K	Buy	6,657 +289	+5%	+$37.2K	0.35%	57
2021 Q2	$862K	Buy	+6,368	New	+$837K	0.35%	60
2020 Q4	$1.23M	Hold	8,719	–	–	0.58%	51
2020 Q3	$972K	Buy	8,719 +428	+5%	+$48K	0.51%	53
2020 Q2	$928K	Buy	8,291 +1,832	+28%	+$180K	0.57%	52
2020 Q1	$500K	Buy	6,459 +1,591	+33%	+$141K	0.39%	52
2019 Q4	$463K	Sell	4,868 -2,381	-33%	-$206K	0.27%	69
2019 Q3	$553K	Sell	7,249 -47	-0.6%	-$3.91K	0.33%	60
2019 Q2	$640K	Buy	7,296 +4,682	+179%	+$399K	0.38%	52
2019 Q1	$237K	Buy	+2,614	New	+$222K	0.14%	91
2017 Q3	–	Sell	-178	Closed	-$13.7K	–	317
2017 Q2	$13.7K	Buy	+178	New	+$12.6K	0.01%	274